Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: A long-term chart review-Reference-Cited by-同舟云学术

Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: A long-term chart review

Published:2013-01 Issue:1 Volume:14 Page:30-36
ISSN:1389-9457
Container-title:Sleep Medicine
language:en
Short-container-title:Sleep Medicine

Author:

Nittur Nandini,Konofal Eric,Dauvilliers Yves,Franco Patricia,Leu-Semenescu Smaranda,Cock Valérie Cochen De,Inocente Clara O.,Bayard Sophie,Scholtz Sabine,Lecendreux Michel,Arnulf Isabelle

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. EFNS guidelines on management of narcolepsy;Billiard;Eur J Neurol,2006

2. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin;Morgenthaler;Sleep,2007

3. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin−/−mice and patients;Lin;Neurobiol Dis,2008

4. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy;Lavault;Sleep Med,2011

5. Chemistry and pharmacology of mazindol;Gogerty;Triangle,1976

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From past to future: 50 years of pharmacological interventions to treat narcolepsy;Pharmacology Biochemistry and Behavior;2024-08

2. Diagnostic challenges and burden of idiopathic hypersomnia: a systematic literature review;Sleep Advances;2024-01-01

3. Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia;Journal of Clinical Sleep Medicine;2023-10

4. Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion;Sleep Medicine Reviews;2023-06

5. Idiopathic Hypersomnia: Neurobiology, Diagnosis, and Management;CNS Drugs;2023-04